From Merck & Co., Inc. (NYSE:MRK) recent downsizing announcement to the sale or merger of other locally based companies, including Cephalon Inc., the region’s bustling life-sciences sector is undergoing big changes — with big implications for the Delaware Valley. Merck & Co., Inc. (NYSE:MRK) stock opened at $51.27 in last session, and closed at $51.98, while the day range of stock is $51.13 – $52.17. The stock showed a negative weekly performance of -0.99%.
Pfizer Inc. (NYSE:PFE) has reported top-line results from a phase III study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic low back pain. In this study, ALO-02 met the primary efficacy endpoint, demonstrating a statistically significant difference from placebo. Pfizer Inc. (NYSE:PFE) stock opened at $30.86, in last session and closed at $30.09, by losing -2.97%. The 52 week range of the stock is $26.76 – $32.50. Company’s market capitalization is $195.02 billion.
Bristol-Myers Squibb Co. (NYSE:BMY) issued an update on its FY14 earnings guidance on Friday morning. The company provided EPS guidance of $1.65-1.80 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.77, AnalystRatings.Net reports. Bristol-Myers Squibb Co (NYSE:BMY) stock decreased -5.58% and finished the last session at $50.94. The EPS of the stock remained 1.66. Company’s market capitalization is $83.87 billion.
A recent ruling by the Federal Circuit in Novartis AG (ADR) (NYSE:NVS) resolved the issues raised in the Exelixis I,Exelixis II and Novartis decisions regarding the effect of a Request for Continued Examination (RCE) on patent term adjustment (PTA). Novartis AG (ADR) (NYSE:NVS) stock opened the session at $80.41, and closed the session at $79.84. The 52 week range of the stock remained $66.65 – $82.02 and the day range was $79.64 – $80.50.